Navigation Links
AMERIGROUP Corporation to Present at the Goldman Sachs 29th Annual Global Healthcare Conference on June 11
Date:5/30/2008

VIRGINIA BEACH, Va., May 30 /PRNewswire-FirstCall/ -- AMERIGROUP Corporation (NYSE: AGP) today announced that it will participate in the Goldman Sachs Global Healthcare Conference on June 11 at Dana Point, California.

A live webcast of the Company's presentation, which begins Wednesday, June 11 at 5:40 p.m. Eastern Time, can be accessed on AMERIGROUP's Web site, http://www.amerigroupcorp.com, on the investors' page. A replay of the webcast will be available for 30 days after the presentation and can be accessed at the same Web address.

AMERIGROUP Corporation, headquartered in Virginia Beach, Virginia, improves healthcare access and quality for the financially vulnerable, seniors and people with disabilities by developing innovative managed health services for the public sector. Through its subsidiaries, AMERIGROUP Corporation serves approximately 1.7 million people in the District of Columbia, Florida, Georgia, Maryland, New Jersey, New Mexico, New York, Ohio, South Carolina, Tennessee, Texas and Virginia. For more information, visit http://www.amerigroupcorp.com

CONTACT:

Investors: Julie Loftus Trudell News Media: Kent Jenkins Jr.

Senior Vice President, Senior Vice President,

Investor Relations Media Relations

AMERIGROUP Corporation AMERIGROUP Corporation

(757) 321-3597 (757) 769-7859


'/>"/>
SOURCE AMERIGROUP Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. AMERIGROUP to Acquire Memphis Health Plan
2. AMERIGROUP Corporation to Host Investor Day
3. AMERIGROUP Names Mary McCluskey, MD, Chief Medical Officer
4. AMERIGROUP Contracts with Federal Government to Offer Medicare Advantage Health Plans in Seven States
5. AMERIGROUP Corporation to Discuss Third Quarter Earnings on October 25
6. AMERIGROUP to Participate in National Disability Mentoring Day
7. AMERIGROUP Corporation to Present at the 2007 Credit Suisse Healthcare Conference on November 13
8. AMERIGROUP Corporation to Present at the Merrill Lynch Health Services Investor Conference on November 27
9. AMERIGROUP Community Care Provides Doctors Office Makeover in Houston
10. AMERIGROUP Foundation Awards $100,000 to Grady Health System Foundation in Atlanta
11. AMERIGROUP Community Care of Georgia Wins New Health Plan Accreditation from NCQA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... Central Nebraska Imaging (CNI) is pleased to ... new logo and optimized website. , CNI’s ... to expert diagnostic imaging, centered on patient care. The ... be a resource for Nebraska patients and a tool ... and referral functionality, video content and resources to understand ...
(Date:3/5/2015)... Rosa, CA (PRWEB) March 05, 2015 SuperCloset ... a SuperPro! The series aims to teach viewers everything ... garden with hydroponics. Grow Like a SuperPro takes you from ... between. From how to clone, to how to prune Grow ... growing. They are offering the whole series for download for ...
(Date:3/5/2015)... 2015 Califia Farms , the ... Natural Products Expo West that its popular ready-to-drink Vanilla ... soy and dairy free. Califia Farms Vegan Protein Almondmilk ... are packed with six grams of an innovative nutrient-dense, ... B vitamins and magnesium. , Protein is an essential ...
(Date:3/5/2015)... For PASCHA Chocolate, less is more. ... robust flavor of the cacao bean bursts through without ... free from peanuts, nuts, dairy, soy, eggs, fish, wheat, ... 8th at Expo West., ,    NEW PASCHA Make ... new ground with their New PASCHA Make Me Smile! ...
(Date:3/5/2015)... Today, Earth Source Organics (ESO) ... pollution-free electricity through a partnership with national Clean ... Arcadia Power Clean Energy Partner, ESO now meets ... requirements, joining national brands such as Whole Foods, ... Earth Source Organics joins a growing community of ...
Breaking Medicine News(10 mins):Health News:Central Nebraska Imaging Center Gets Rebranding 2Health News:Califia Farms Vegan Protein and New Single Serve Almondmilks to Hit Supermarket Shelves this Month 2Health News:Califia Farms Vegan Protein and New Single Serve Almondmilks to Hit Supermarket Shelves this Month 3Health News:PASCHA Allergen Free Organic Chocolate to Appear at Natural Products Expo West March 6-8, 2015 2Health News:Earth Source Organics to Run on Clean Energy from Arcadia Power 2
... at the University of Queensland in Australia have found a ... Pacific, to be safe and effective in reducing anxiety. , ... Psychopharmacology , the results of a world-first clinical trial ... in treating anxiety and improving mood. The Kava was prescribed ...
... older people to reduce their risk of developing heart ... D in the skin and older people are more ... the natural aging process and changes in lifestyle. , ... D deficiency is significantly associated with metabolic syndrome, a ...
... Move Health Reform ForwardWASHINGTON, May 11 Statement attributable ... health reform that provides coverage and high quality, affordable ... costs strain individual, business and government budgets, and projected ... AMA is committed to action to help achieve greater ...
... David Cornfield, MD, the chief of pulmonary, ... Children,s Hospital at Stanford, has been elected president ... http://www.newscom.com/cgi-bin/prnh/20090511/SF14213 )Beginning this month, Cornfield is leading ... a one-year term. "It,s a great honor to ...
... or have debt or access problems, study finds , , MONDAY, ... the economy began, women were more likely than men to ... they need. , So finds a report released Monday by ... half of women surveyed said they had problems getting care ...
... Solutions(TM) secures 24/7 physician access to serve offshore ... InPlace Medical Solutions, the first full-service offshore medical ... in the offshore medical industry - securing physician ... its clients. All services are provided by ...
Cached Medicine News:Health News:Research finds kava safe and effective 2Health News:Research says older people need more sun 2Health News:Packard/Stanford Physician to Lead Society for Pediatric Research 2Health News:Most Women Struggle With Rising Health Care Costs 2Health News:Most Women Struggle With Rising Health Care Costs 3Health News:The Doctor Is In, Around the Clock 2Health News:The Doctor Is In, Around the Clock 3
(Date:3/5/2015)... , March 5, 2015  Relmada Therapeutics, ... therapies for the treatment of chronic pain, today ... researchers to advisory roles. The panel of experts ... programs and efforts to advance the company pipeline ... They bring expertise in a range of areas ...
(Date:3/5/2015)... 5, 2015 - Cross reference: ... http://www.epa.eu ) - Hitachi Medical Systems ... generazione di OASIS* all,ECR 2015. Si tratta di un ... da 1.2 T che migliora la capacità diagnostica dei ... al comfort del paziente. Le nuove funzionalità di OASIS ...
(Date:3/5/2015)... HAMPTON, N.J. , March 5, 2015 ... a leading global specialty biopharmaceutical company, and Ikaria, Inc. ... have entered into a definitive agreement under which a ... Madison Dearborn -led investor group in a transaction ... to customary closing conditions, the parties expect the transaction ...
Breaking Medicine Technology:Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 2Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 3Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 4Hitachi Medical Systems Europe lancia la nuova generazione di OASIS*: Il sistema di RM aperta ad alto campo da 1.2 T. Ancora più valore al paziente 2Hitachi Medical Systems Europe lancia la nuova generazione di OASIS*: Il sistema di RM aperta ad alto campo da 1.2 T. Ancora più valore al paziente 3Hitachi Medical Systems Europe lancia la nuova generazione di OASIS*: Il sistema di RM aperta ad alto campo da 1.2 T. Ancora più valore al paziente 4Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 2Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 3Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 4Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 5Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 6Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 7Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 8Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 9
... III pivotal trial demonstrate safety and,efficacy of first ... severe COPD --, NAPA, Calif., May 16, 2007 ... presentations will be given at the,International Conference of ... at the Moscone Center in San Francisco. The,presentations ...
... WIRE)--May 17, 2007 - Results,published this week in ... (Quadrivalent Human Papillomavirus (Types 6, 11,16, 18) Recombinant ... and vaginal dysplasias caused by HPV,types 16 and ... 100 percent protection was observed in women who ...
Cached Medicine Technology:Clinical Trial Data for Perforomist Inhalation Solution to be,Presented at ATS on May 20, 2007 2Clinical Trial Data for Perforomist Inhalation Solution to be,Presented at ATS on May 20, 2007 3Clinical Trial Data for Perforomist Inhalation Solution to be,Presented at ATS on May 20, 2007 4Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 2Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 3Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 4Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 5Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 6Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 7Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 8Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 9Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 10Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 11Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 12Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 13Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 14Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 15Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 16Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 17Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 18Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 19Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 20Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 21Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 22Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 23Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 24Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 25Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 26Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 27Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 28Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 29Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 30Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 31Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 32
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
... Many special order products are offered as ... long lengths. The modular instruments may be ... options such as ratchets, insulation and flush ... Mediflex stock. Customer specifications may affect delivery ...
Medicine Products: